Search Results 1861-1870 of 14774 for anti-TNF drugs

  1. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Use of an investigational anti-cancer drug within 28 days preceding the first dose of dabrafenib; Patients receiving any medications or substances that are ...

  2. Ophthalmology News - Medical Professionals - Mayo Clinic

    Intravitreal anti-VEGF pharmacotherapy safe for treatment of diabetic macular edema. Study offers further evidence of a relatively safe systemic risk profile ...

  3. Influenza Virus Vaccine (Intradermal Route, Intramuscular Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. In 1976, a number of people who received the “swine flu” influenza vaccine developed ...

  4. TRC-PAD Program: In-Clinic Trial-Ready Cohort - Mayo Clinic

    Treatment with another anti-amyloid investigational drug or other intervention within 12 months. Enrolled in another interventional clinical trial within ...

  5. Talc (Intrapleural Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Sclerosol Intrapleural; Steritalc. Descriptions.

  6. Overview - Systems Biology and Translational Medicine: Akhilesh Pandey - Mayo Clinic Research

    Our goal is to apply multi-omics technologies for improving and individualizing diagnosis and treatment of cancer and other conditions. Overview. The Systems ...

  7. Technetium Tc 99m Sulfurcolloid (Injection Route, Route Not Applicable) Description and Brand Names - Mayo Clinic

    Technetium Tc 99m sulfur colloid injection is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain ...

  8. Zanubrutinib (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Mayo Clinic researchers uncover new agents that eliminate cells associated with age-related diseases

    “At Mayo Clinic, we discovered the first senolytic drugs – agents that selectively eliminate senescent cells while leaving normal cells unaffected. These ...

  10. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

    This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM). ... Participants taking an enzyme-inducing anti- ...